ATRC-501
N/A
Report date: 2023/06/07 20:00:31
Base Information
Drug NameATRC-501
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAtreca Inc
China Registration ClassN/A
Develop Information
Active CompaniesAtreca IncGates Medical Research InstituteBill & Melinda Gates Medical Research Institute
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A